G03HB01 • cyproterone + ethinyl estradiol • Genito urinary system and sex hormones | Antiandrogens | Antiandrogens and estrogens
The combination of cyproterone and ethinylestradiol is used for the treatment of severe acne, hirsutism, and other conditions caused by excess androgens in women. Cyproterone is an antiandrogen that reduces the effects of androgen hormones, while ethinylestradiol is an estrogen that regulates the menstrual cycle.
The medication is taken orally, as directed by a doctor, usually once daily at the same time each day. It is important for patients to follow the treatment regimen to achieve maximum benefits.
Patients should be aware of potential side effects, such as nausea, headaches, or mood changes. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, headaches, and breast tenderness. In rare cases, severe reactions such as venous thromboembolism or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
Substance: cyproterone + ethinyl estradiol
Date of last drug list: 01-07-2013
Commercial code: W43802001
Pharmaceutical form: tablets
Quantity: 1
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.